Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Shareholders' Equity (Unaudited)

v3.19.2
Consolidated Statements Of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock and Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2017 $ 29,260 $ 225,012 $ (576) $ (195,177)
Issuance of common stock upon exercise of options   2    
Stock offering costs   (38)    
Stock-based compensation expense   1,133    
Other comprehensive (loss) income     (34)  
Net loss (9,932)     (9,932)
Ending balance at Jun. 30, 2018 20,390 226,109 (610) (205,109)
Beginning balance at Mar. 31, 2018 24,937 225,626 (492) (200,198)
Stock-based compensation expense   483    
Other comprehensive (loss) income     (118)  
Net loss (4,911)     (4,911)
Ending balance at Jun. 30, 2018 20,390 226,109 (610) (205,109)
Beginning balance at Dec. 31, 2018 11,089 228,451 (670) (216,692)
Issuance of common stock upon exercise of options   3    
Liability award settlement   209    
Stock-based compensation expense   1,122    
Other comprehensive (loss) income     (41)  
Net loss (8,799)     (8,799)
Warrants issued in connection with debt instruments   209    
Ending balance at Jun. 30, 2019 3,792 229,994 (711) (225,491)
Beginning balance at Mar. 31, 2019 6,973 229,290 (725) (221,592)
Liability award settlement   7    
Stock-based compensation expense   488    
Other comprehensive (loss) income     14  
Net loss (3,899)     (3,899)
Warrants issued in connection with debt instruments   209    
Ending balance at Jun. 30, 2019 $ 3,792 $ 229,994 $ (711) $ (225,491)